These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 7285873)

  • 21. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS; Parker CJ; McCague R; Jordan VC
    Mol Pharmacol; 1991 Mar; 39(3):421-8. PubMed ID: 2005879
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of estrogen receptor turnover in uterine cells in vitro and in uteri in vivo.
    Nardulli AM; Katzenellenbogen BS
    Endocrinology; 1986 Nov; 119(5):2038-46. PubMed ID: 3533520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiestrogenic action of 3-hydroxytamoxifen in the human breast cancer cell line MCF-7.
    Roos W; Oeze L; Löser R; Eppenberger U
    J Natl Cancer Inst; 1983 Jul; 71(1):55-9. PubMed ID: 6575210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desmethylnafoxidine aziridine: an electrophilic affinity label for the estrogen receptor with high efficiency and selectivity.
    Simpson DM; Elliston JF; Katzenellenbogen JA
    J Steroid Biochem; 1987 Sep; 28(3):233-45. PubMed ID: 3657146
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer.
    Waseda N; Kato Y; Imura H; Kurata M
    Cancer Res; 1981 May; 41(5):1984-8. PubMed ID: 7214366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen.
    Bentrem D; Dardes R; Liu H; MacGregor-Schafer J; Zapf J; Jordan V
    Endocrinology; 2001 Feb; 142(2):838-46. PubMed ID: 11159857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonistic effect of triphenylethylenic antiestrogens on the association of estrogen receptor to calmodulin.
    Bouhoute A; Leclercq G
    Biochem Biophys Res Commun; 1992 May; 184(3):1432-40. PubMed ID: 1590802
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of estrogen and progesterone receptors and the dissociated regulation of growth and progesterone receptor stimulation by estrogen in MDA-MB-134 human breast cancer cells.
    Reiner GC; Katzenellenbogen BS
    Cancer Res; 1986 Mar; 46(3):1124-31. PubMed ID: 3943090
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction with type II estrogen binding sites and antiproliferative activity of tamoxifen and quercetin in human non-small-cell lung cancer.
    Caltagirone S; Ranelletti FO; Rinelli A; Maggiano N; Colasante A; Musiani P; Aiello FB; Piantelli M
    Am J Respir Cell Mol Biol; 1997 Jul; 17(1):51-9. PubMed ID: 9224209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic, pituitary and uterine cytoplasmic and nuclear oestrogen receptors and their relationship to the serum concentration of tamoxifen and its metabolite, 4-hydroxytamoxifen, in the ovariectomized rat.
    Bowman SP; Leake A; Morris ID
    J Endocrinol; 1982 Aug; 94(2):167-75. PubMed ID: 7108408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new triphenylethylene compound, Fc-1157a. I. Hormonal effects.
    Kallio S; Kangas L; Blanco G; Johansson R; Karjalainen A; Perilä M; Pippo I; Sundquist H; Södervall M; Toivola R
    Cancer Chemother Pharmacol; 1986; 17(2):103-8. PubMed ID: 2941176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [125I]iododesethyl tamoxifen aziridine: synthesis and covalent labeling of the estrogen receptor with an iodine-labeled affinity label.
    Salituro FG; Carlson KE; Elliston JF; Katzenellenbogen BS; Katzenellenbogen JA
    Steroids; 1986; 48(5-6):287-313. PubMed ID: 3445283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Estrogen receptor translocation and replenishment by the antiestrogen tamoxifen.
    Koseki Y; Zava DT; Chamness GC; McGuire WL
    Endocrinology; 1977 Oct; 101(4):1104-10. PubMed ID: 561688
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of tamoxifen on cytosolic estrogen receptor in the different parts of fallopian tube and uterus during ovum transport.
    Gupta JS; Roy SK
    Exp Clin Endocrinol; 1987 Dec; 90(3):293-300. PubMed ID: 3450528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiestrogen pharmacology and mechanism of action.
    Katzenellenbogen BS; Miller MA; Eckert RL; Sudo K
    J Steroid Biochem; 1983 Jul; 19(1A):59-68. PubMed ID: 6887873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.
    Eckert RL; Katzenellenbogen BS
    Cancer Res; 1982 Jan; 42(1):139-44. PubMed ID: 7053842
    [No Abstract]   [Full Text] [Related]  

  • 37. Homologs of idoxifene: variation of estrogen receptor binding and calmodulin antagonism with chain length.
    Hardcastle IR; Rowlands MG; Grimshaw RM; Houghton J; Jarman M
    J Med Chem; 1996 Feb; 39(4):999-1004. PubMed ID: 8632423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptor sites on chromatin for receptor bound by estrogen versus antiestrogen in antiestrogen-sensitive and -resistant MCF-7 cells.
    Singh RK; Ruh MF; Butler WB; Ruh TS
    Endocrinology; 1986 Mar; 118(3):1087-95. PubMed ID: 3948766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018.
    Bronzert DA; Greene GL; Lippman ME
    Endocrinology; 1985 Oct; 117(4):1409-17. PubMed ID: 4029083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunorecognition of cytosol and nuclear estradiol receptor of fetal guinea pig uterus using monoclonal antibody.
    Giambiagi N; Pasqualini JR
    Endocrinology; 1982 Mar; 110(3):1067-9. PubMed ID: 6173208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.